Nasdaq: MLYS
Mineralys Therapeutics insiders
The officers, directors and 10% owners of Mineralys Therapeutics, Inc. who hold the most stock, valued at the live MLYS price.
$14.16
MLYS today +$380K (+2.76%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their MLYS stock
- $119M
- Market value
- $1.25B
- Held by ranked insiders
- 9.53%
Insiders by value of MLYS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Brian Taylor Slingsby | Director | 7,910,038 | $112M | 8.93% | 1383rd |
| 2 | Jon Congleton | Chief Executive Officer | 528,621 | $7.5M | 0.60% | 10851st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Mineralys Therapeutics; see each profile for the filing.